Log In
BCIQ
Print this Print this
 

IX-01

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionOxytocin receptor (OXTR) antagonist
Molecular Target Oxytocin receptor (OXTR)
Mechanism of ActionOxytocin inhibitor
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase II
Standard IndicationPremature ejaculation
Indication DetailsTreat premature ejaculation
Regulatory Designation
PartnerIxchelsis Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/12/2013

Undisclosed

0

Undisclosed

08/12/2013

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today